HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals-Reference-Cited by-同舟云学术

HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals

Published:2018-10 Issue:10 Volume:26 Page:2496-2506
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Sung Julia A.,Patel Shabnum,Clohosey Matthew L.,Roesch Lauren,Tripic Tamara,Kuruc JoAnn D.,Archin Nancie,Hanley Patrick J.,Cruz C. Russell,Goonetilleke Nilu,Eron Joseph J.,Rooney Clio M.,Gay Cynthia L.,Bollard Catherine M.,Margolis David M.

Funder

NIH

amfAR

Cancer Center

NIH-NHLBI Production Assistance for Cell Therapy

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference75 articles.

1. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection;Chun;Nature,1997

2. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency;Chun;Nat. Med.,1995

3. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy;Chun;Proc. Natl. Acad. Sci. USA,1997

4. Precise quantitation of the latent HIV-1 reservoir: implications for eradication strategies;Crooks;J. Infect. Dis.,2015

5. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells;Siliciano;Nat. Med.,2003

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of cell therapy in the treatment of virus-associated cancers;Nature Reviews Clinical Oncology;2024-08-19

2. Environmental monitoring of current good manufacturing practices cleanroom facilities for manufacturing of cellular therapy products in an academic hospital setting;Cytotherapy;2024-06

3. The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy;The Journal of Infectious Diseases;2024-02-13

4. Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells;PLOS Pathogens;2023-12-15

5. Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through cis and trans mechanisms;Frontiers in Immunology;2023-09-14